Literature DB >> 12759626

Positive blood cultures in sickle cell disease: time to positivity and clinical outcome.

Cynthia F Norris1, Kim Smith-Whitley, Karin L McGowan.   

Abstract

PURPOSE: To prospectively identify all cases of bacteremia in children with sickle cell disease (SCD), establish time to positivity for various microorganisms, correlate clinical findings with microbiology data, and determine the antibiotic resistance pattern of the pneumococcal isolates.
METHODS: All positive blood cultures from children with SCD followed at the Children's Hospital of Philadelphia from January 1993 through May 2001 were included. Isolates were classified as pathogen or contaminant. Demographic and clinical information was abstracted from the medical records. Time to positivity and antibiotic resistance data were generated in the microbiology laboratory.
RESULTS: One hundred forty-one positive blood culture bottles were obtained during distinct febrile episodes. Thirty-nine percent contained pathogens and 61% contained contaminants. The average time to positivity was 17.1 hours in the pathogen group and 29.5 hours in the contaminant group (P < 0.0001). Streptococcus pneumoniae was the most common pathogen (42% of total), with a mean patient age of 3.5 years. Gram-negative rods were the second most common organism (28% of total), with a mean patient age of 8.1 years. Thirty-one percent of the pneumococcal isolates were resistant to penicillin. Thirty-five percent of the pneumococcal isolates grew from children with a focus of infection. Acute chest syndrome was noted in 26% of patients with a positive blood culture for S. pneumoniae. Sixty-seven percent of Salmonella isolates and 50% of Staphylococcus aureus isolates grew from patients who developed osteomyelitis.
CONCLUSIONS: The average time to positivity for pathogens can be used in conjunction with other factors to determine the length of observation required for children with SCD who present with febrile illness. Chest radiographs should be obtained on children with SCD who are bacteremic with S. pneumoniae. Bone scans should be obtained on children with SCD who are bacteremic with Salmonella or S. aureus.

Entities:  

Mesh:

Year:  2003        PMID: 12759626     DOI: 10.1097/00043426-200305000-00008

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

1.  Impairment of neutrophil oxidative burst in children with sickle cell disease is associated with heme oxygenase-1.

Authors:  Ceri Evans; Katharine Orf; Erzsebet Horvath; Michael Levin; Josu De La Fuente; Subarna Chakravorty; Aubrey J Cunnington
Journal:  Haematologica       Date:  2015-08-27       Impact factor: 9.941

Review 2.  The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity.

Authors:  Bertrand Boisson
Journal:  Hum Genet       Date:  2020-01-24       Impact factor: 4.132

3.  Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection.

Authors:  Alexandre R Marra; Michael B Edmond; Betty A Forbes; Richard P Wenzel; Gonzalo M L Bearman
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Outcomes of febrile events in pediatric patients with sickle cell anemia.

Authors:  Krishnaveni Sirigaddi; Inmaculada Aban; Amelia Jantz; Brandi M Pernell; Lee M Hilliard; Smita Bhatia; Jeffrey D Lebensburger
Journal:  Pediatr Blood Cancer       Date:  2018-08-01       Impact factor: 3.167

5.  Bordetella holmesii bacteremia in sickle cell disease.

Authors:  Timothy L McCavit; Steve Grube; Paula Revell; Charles T Quinn
Journal:  Pediatr Blood Cancer       Date:  2008-12       Impact factor: 3.167

6.  Time to positivity in blood cultures of adults with Streptococcus pneumoniae bacteremia.

Authors:  Galo Peralta; María José Rodríguez-Lera; Jose Carlos Garrido; Luis Ansorena; María Pía Roiz
Journal:  BMC Infect Dis       Date:  2006-04-27       Impact factor: 3.090

Review 7.  Life-Threatening Infectious Complications in Sickle Cell Disease: A Concise Narrative Review.

Authors:  Dominik Ochocinski; Mansi Dalal; L Vandy Black; Silvana Carr; Judy Lew; Kevin Sullivan; Niranjan Kissoon
Journal:  Front Pediatr       Date:  2020-02-20       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.